This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Patient Care Work Group | Maturity Level: 1 | Draft | Use Context: Any |
This is a value set defined by the FHIR project.
Summary
Defining URL: | http://hl7.org/fhir/ValueSet/adverse-event-causality-assess |
Version: | 4.6.0 |
Name: | AdverseEventCausalityAssessment |
Title: | AdverseEventCausalityAssessment |
Definition: | Codes for the assessment of whether the entity caused the event. |
Committee: | Patient Care Work Group |
OID: | 2.16.840.1.113883.4.642.3.840 (for OID based terminology systems) |
Source Resource | XML / JSON |
This value set is used in the following places:
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
This expansion generated 15 Apr 2021
This value set contains 6 concepts
Expansion based on AdverseEventCausalityAssessment v4.6.0 (CodeSystem)
All codes from system http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
Code | Display | Definition |
certain | Certain | i) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary. |
probably-likely | Probably/Likely | i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required. |
possible | Possible | i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear. |
unlikely | Unlikely | i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations. |
conditional-classified | Conditional/Classified | i) Event or laboratory test abnormality; ii) More data for proper assessment needed; or iii) Additional data under examination. |
unassessable-unclassifiable | Unassessable/Unclassifiable | i) Report suggesting an adverse reaction; ii) Cannot be judged because information is insufficient or contradictory; or iii) Data cannot be supplemented or verified. |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |